Immersive Virtual Reality and Physical Exercise on Cognitive and Functional Performance in Hospitalized Older Patients
MOTOMED
Effects of Immersive Virtual Reality and/or Multicomponent Physical Exercise on Cognitive and Functional Performance in Hospitalized Older Patients With Severe Functional Dependency: Study Protocol for a Randomized Clinical Trial
1 other identifier
interventional
212
1 country
1
Brief Summary
This study will be conducted in a hospital in Spain to investigate how a special intervention using immersive virtual reality technology can benefit hospitalized older adults with difficulties in their daily functionality. The main objective of this study is to evaluate whether a cognitive stimulation intervention through immersive virtual reality, along with specific physical exercises, can improve the cognitive and physical function of hospitalized older patients. It is expected that this innovative intervention will have a positive impact on the quality of life of these patients. Participants eligible for the study must be over 75 years old, have severe functional dependency upon hospital admission, and be willing to participate. Those with severe dementia or other terminal illnesses will be excluded. Participants will be randomly assigned to one of four study groups: a control group without intervention and three intervention groups, including viewing Spanish landscapes through virtual reality, performing specific physical exercises, or a combination of both interventions. At the end of the study, various aspects such as cognitive and physical function, mood, quality of life, muscle strength, and acceptance of virtual reality technology by patients will be evaluated. This study aims to provide new insights into the care of hospitalized older adults and explore innovative ways to improve their well-being during their hospital stay
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2024
CompletedFirst Posted
Study publicly available on registry
April 1, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedJanuary 13, 2025
January 1, 2025
1 year
March 25, 2024
January 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mini-Mental State Examination (MMSE)
Cognitive evolution
Baseline, day 3, at discharge and 1 month after discharge
Secondary Outcomes (1)
Isometric handgrip strength
Baseline, day 3, at discharge and 1 month after discharge
Study Arms (4)
Control
NO INTERVENTIONControl group
immersive virtual reality
EXPERIMENTALPatients use virtual reality
multicomponent physical exercise intervention
EXPERIMENTALIndividualized exercise intervention
Immersive virtual reality and multicomponent physical exercise intervention
EXPERIMENTALBoth
Interventions
Immersive virtual reality
individualized exercise
Eligibility Criteria
You may qualify if:
- Age ≥ 75 years Clinica Stability Expected length of stay ≥ 5 days Being able to communicate and collaborate with the research team
You may not qualify if:
- Barthel Index score ≥ 60 at admission Refusal to sign the informed consent by the patient/legal guardian or inability to obtain it Life expectancy less than three months End-stage disease Severe level of major neurocognitive disorder (GDS 7)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario de Navarra
Pamplona, Navarre, 31008, Spain
Related Publications (2)
Cuevas-Lara C, Saez de Asteasu ML, Ramirez-Velez R, Izquierdo M, Zambom-Ferraresi F, Antonanzas-Valencia C, Galbete A, Zambom-Ferraresi F, Martinez-Velilla N. Effects of game-based interventions on functional capacity in acutely hospitalised older adults: results of an open-label non-randomised clinical trial. Age Ageing. 2022 Jan 6;51(1):afab247. doi: 10.1093/ageing/afab247.
PMID: 35077558RESULTde la Casa-Marin A, Zambom-Ferraresi F, Ferrara MC, Ollo-Martinez I, Galbete A, Gonzalez-Glaria B, Moral-Cuesta D, Marin-Epelde I, Chenhuichen C, Lorente-Escudero M, Molero-de-Avila R, Baztan AG, Zambom-Ferraresi F, Martinez-Velilla N. Effects of immersive virtual reality stimulation and/or multicomponent physical exercise on cognitive and functional performance in hospitalized older patients with severe functional dependency: study protocol for a randomized clinical trial. BMC Geriatr. 2024 Nov 8;24(1):924. doi: 10.1186/s12877-024-05516-x.
PMID: 39516806DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Nicolas Martinez-Velilla Dr, PhD
Fundación Miguel Servet - Navarrabiomed
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2024
First Posted
April 1, 2024
Study Start
April 1, 2024
Primary Completion
April 1, 2025
Study Completion
April 1, 2025
Last Updated
January 13, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- After the paper is published
- Access Criteria
- Any reasonable demand
The plan to share anonymized data from a randomized clinical trial in response to reasonable requests focuses on ensuring confidentiality and protecting the privacy of participants. This plan includes fully anonymizing the data, creating a detailed data sharing protocol, establishing an independent data review committee, implementing a clear request procedure, requiring confidentiality agreements to be signed by requestors, and applying robust security measures to protect data integrity. The primary goal is to facilitate access to data to promote transparency and scientific advancement while ensuring respect for the privacy and confidentiality of clinical trial participants. It is important to note that data will be shared under reasonable requests.